| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |